What is Britz?
Britz & Company operates as a cornerstone entity in the laboratory animal science industry, providing essential infrastructure for the biomedical research community. With a legacy spanning over 75 years, the organization specializes in the design, development, and installation of sophisticated animal housing systems and biocontainment units. By prioritizing regulatory compliance and animal welfare, Britz serves a diverse portfolio of clients, including top-tier pharmaceutical companies, academic research universities, and national research institutes. Their technical expertise in creating controlled environments is vital for the integrity of preclinical studies and the advancement of life sciences research globally.
How much funding has Britz raised?
Britz has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Britz
PPP
Public-Private Partnership
What's next for Britz?
With this late-stage capital, Britz is positioned to accelerate its manufacturing capabilities and expand its footprint in the global biocontainment market. The strategic allocation of these funds will likely focus on scaling production to meet the increasing demand for high-compliance research environments. As the biomedical sector continues to prioritize rigorous standards in animal care and experimental precision, Britz is well-equipped to leverage its long-standing industry reputation to capture additional market share. Future growth initiatives will likely involve the integration of advanced monitoring technologies into their existing housing product lines, further cementing their status as a primary provider for the international research community.
See full Britz company page
